Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 4, 2008, Pages 886-891

  Nakas, Apostolos ^a   Trousse, Delphine Sophie ^a   Martin Ucar, Antonio E ^a   Waller, David A ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Malignant pleural mesothelioma; Pleurectomy decortication; Radical surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CELL SURVIVAL; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE COURSE; EPITHELIOID CELL; FEMALE; GENDER; HUMAN; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THORACOTOMY;

AGED; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; THORACOTOMY; TREATMENT OUTCOME;

EID: 52949109762     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.06.010     Document Type: Article

References (25)

1. Weder W., Stahel R.A., Bernhard J., Bodis S., Vogt P., Ballabeni P., Lardinois D., Betticher D., Schmid R., Stupp R., Ris H.B., Jermann M., Mingrone W., Roth A.D., Spiliopoulos A., and Swiss Group for Clinical Cancer Research. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 7 (2007) 1196-1202
2. Martin-Ucar A.E., Edwards J.G., Rengajaran A., Muller S., and Waller D.A. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg 20 6 (2001) 1117-1121
3. Martin-Ucar A.E., Nakas A., Edwards J.G., and Waller D.A. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 5 (2007) 765-770
4. Merritt N., Blewett C.J., Miller J.D., Bennett W.F., Young J.E., and Urschel J.D. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 78 3 (2001) 171-174
5. Sugarbaker D.J., Garcia J.P., Richards W.G., Harpole Jr. D.H., Healy-Baldini E., DeCamp Jr. M.M., Mentzer S.J., Liptay M.J., Strauss G.M., and Swanson S.J. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 224 3 (1996) 288-294
6. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., DeCamp Jr. M.M., Swanson S.J., Bueno R., Lukanich J.M., Baldini E.H., and Mentzer S.J. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 1 (1999) 54-63
7. Sugarbaker D.J., Jaklitsch M.T., Bueno R., Richards W., Lukanich J., Mentzer S.J., Colson Y., Linden P., Chang M., Capalbo L., Oldread E., Neragi-Miandoab S., Swanson S.J., and Zellos L.S. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128 1 (2004) 138-146
8. Rusch V.W., Piantadosi S., and Holmes E.C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A lung cancer study group trial. J Thorac Cardiovasc Surg 102 1 (1991) 1-9
9. Stewart D.J., Martin-Ucar A., Pilling J.E., Edwards J.G., O'Byrne K.J., and Waller D.A. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Ann Thorac Surg 78 1 (2004) 245-252
10. de Perrot M., Uy K., Anraku M., Tsao M.S., Darling G., Waddell T.K., Pierre A.F., Bezjak A., Keshavjee S., and Johnston M.R. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 133 1 (2007) 111-116
11. Edwards J.G., Stewart D.J., Martin-Ucar A., Muller S., Richards C., and Waller D.A. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg 131 5 (2006) 981-987
12. Edwards J.G., Abrams K.R., Leverment J.N., Spyt T.J., Waller D.A., and O'Byrne K.J. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55 9 (2000) 731-735
13. Steele J.P., Klabatsa A., Fennell D.A., Palläska A., Sheaff M.T., Evans M.T., Shamash J., and Rudd R.M. Prognostic factors in mesothelioma. Lung Cancer 49 Suppl. 1 (2005) S49-52
14. Rusch V.W., and Venkatraman E.S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68 5 (1999) 1799-1804
15. Sugarbaker D.J. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 1 2 (2006) 175-176
16. Rusch V.W. Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 9 4 (1997) 367-372
17. Roberts J.R. Surgical treatment of mesothelioma: pleurectomy. Chest 116 6 Suppl. (1999) 446S-449S
18. Pass H.I., Kranda K., Temeck B.K., Feuerstein I., and Steinberg S.M. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol 4 3 (1997) 215-222
19. Lee T.T., Everett D.L., Shu H.K., Jahan T.M., Roach III M., Speight J.L., Cameron R.B., Phillips T.L., Chan A., and Jablons D.M. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 124 6 (2002) 1183-1189
20. Flores R.M., Pass H.I., Seshan V.E., Dycoco J., Zakowski M., Carbone M., Bains M.S., and Rusch V.W. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135 3 (2008) 620-626 626.e1-3
21. Halstead J.C., Lim E., Venkateswaran R.M., Charman S.C., Goddard M., and Ritchie A.J. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 31 3 (2005) 314-320
22. Maggi G., Casadio C., Cianci R., Rena O., and Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 19 3 (2001) 346-350
23. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., Niyikiza C., and Paoletti P. Phase III study of Pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 14 (2003) 2636-2644
24. Nakas A., Martin-Ucar A.E., Edwards J.G., and Waller D.A. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 33 1 (2008) 83-88
25. Pilling J.E., Stewart D.J., Martin-Ucar A.E., Muller S., O'Byrne K.J., and Waller D.A. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 25 4 (2004) 497-501